Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride reduces DHT more effectively than finasteride.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Adalimumab improved folliculitis decalvans in most patients.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Anti-CD19 therapy may help treat SLE and NMOSD.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

A patient developed a blister at the injection site after hepatitis C treatment.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.